Novavax COVID-19 Vaccine Authorized by FDA for Age 12 Years and Older

Upcoming Events

Pneumococcal Vaccine Update for Physicians and Clinicians – April 30

Please join us for a pneumococcal vaccine update webinar on Tuesday, April 30, noon - 1:00 p.m. and hear from Lynn Fisher, MD, family physician and Gretchen Homan, MD, pediatrician, who will provide updates impacting adult pneumococcal vaccine recommendations for adult and pediatric patients, respectively and Monica Pando, RN, VFC coordinator, who will discuss navigating these updates from a clinic perspective.

careLearning Informational Webinar - May 1

In this webinar you will gain practical knowledge of how the careLearning system will help you organize and manage your education. careLearning is non-profit member service of The Kansas Hospital Association and over 40 other state hospital associations.

KARQM Education Program - May 2

The Kansas Association of Risk and Quality Management was created to promote the delivery of quality health care and the practice of risk management in Kansas health care facilities. Membership includes risk and quality management professionals in health care facilities or health-related organizations.

Educational Webinar: How Do Your Hospital Finances Measure Up? – May 2

Join Healthworks and KHA for an educational session at 2:00 p.m. on May 2 to learn how to utilize QHis financial benchmarking tool effectively. Shannan Flach, vice president health care finance and reimbursement and Sally Othmer, vice president data and strategic analytics will be joined by Wes Garrison, founder, Databasically to walk through the tool including the easy-upload process, reviewing the QHi financial measures available and to demonstrating how to run and schedule reports.

Opioid Educational Webinar: Partnering to Increase Access to SUD Treatment – May 3

Please join us on May 3 to hear how hospitals and communities are partnering to increase access to substance use disorder treatment and harm reduction. The program has been approved for 1.0 contact hours of continuing nursing education and pending approval for 1.0 contact hours of continuing pharmacy education. There is no charge to attend as this program is funded through a grant from our partners at DCCCA.

Current Report Articles

‹‹ Back To List

Novavax COVID-19 Vaccine Authorized by FDA for Age 12 Years and Older

COVID19 Vaccine (Oct. 6, 2023) – On Oct. 3, the Food and Drug Administration announced the agency had authorized the Novavax 2023 – 2024 COVID-19 Vaccine, Adjuvanted. The original monovalent Novavax COVID-19 Vaccine is no longer authorized for use in the U.S. Novavax COVID-19 Vaccine, Adjuvanted (2023-2024 Formula), is authorized for use in individuals 12 years of age and older as follows:

Individuals previously vaccinated with any COVID-19 vaccine: one dose of Novavax COVID-19 Vaccine, Adjuvanted (2023-2024 Formula) is administered at least two months after receipt of the last previous dose of an original monovalent (Original) or bivalent (Original and Omicron BA.4/BA.5) COVID-19 vaccine.
For individuals not previously vaccinated with any COVID-19 vaccine: two doses of Novavax COVID-19 Vaccine, Adjuvanted (2023-2024 Formula), are administered three weeks apart.
Immunocompromised individuals: an additional dose of Novavax COVID-19 Vaccine, Adjuvanted (2023-2024 Formula), may be administered at least two months following the last dose of a COVID-19 vaccine (2023-2024 Formula). Additional doses of Novavax COVID-19 Vaccine, Adjuvanted (2023-2024 Formula), may be administered at the discretion of the health care provider, taking into consideration the individual's clinical circumstances. The timing of the additional doses may be based on the individual's clinical circumstances.

For detailed information, see the fact sheet for health care providers.
--Karen Braman

‹‹ Back To List

Communications

Upcoming Events

Recent News